DURHAM — An Iqvia Holdings Inc. board member sold $122 million of stock in the health information technologies and clinical research company last week, according to a Form 4 filed with the Securities and Exchange Commission.
John Connaughton and Bain Capital Investors sold 868,684 shares he oversaw at an average price of $140.80. He still oversees an investment of 2,015,534 shares valued at more than $285 million.
The transactions were made March 8.
Connaughton has served on Iqvia’s board since October 2016 and has been a managing partner of Bain Capital since 1997.
John Connaughton far left) with Mark Vitner, Harry Davis, Mike Walden at the 16th annual Economic Forecast Forum.
The company, based in Durham, provides biopharmaceutical research analytics, which use data and science to help health care clients find better solutions for their patients.
Iqvia has approximately 58,000 employees in more than 100 countries. The company’s approach to human data science is powered by the Iqvia Core, driving unique actionable insights at the intersection of big data, transformative technology and analytics with extensive domain expertise.
Iqvia shares closed Wednesday at $141.55, up $1.70 or 1.22 percent.
This story is from the North Carolina Business News Wire, a service of the UNC-Chapel Hill School of Media and Journalism.
